Kate Turner

Kate Turner has a solid background in clinical research and operations. Kate is currently serving as an Associate Director of Clinical Operations at Geron Corporation since June 2022. Prior to this, they worked at Parexel as a Senior Biotech Clinical Operations Leader from April 2021 to May 2022 and as a Biotech Clinical Operations Lead from November 2018 to April 2021. Kate also has experience working at Duke Clinical Research Institute as a Lead Clinical Research Associate and Clinical Research Associate III, Lead from March 2016 to November 2018 and October 2015 to March 2016 respectively. Kate has previously held positions at PAREXEL as a Clinical Monitoring Associate II, at INC Research as a Clinical Research Associate II, and at Covance as a Clinical Research Associate I and Clinical Research Assistant.

Kate Turner completed an Associate of Arts (A.A.) degree from Rowan College at Burlington County from 2007 to 2009. Following this, they attended Rutgers University - Camden from 2009 to 2011, where they obtained a Bachelor of Arts (B.A.) degree in Biology, General.